Joakim Dillner (Former)
81 – 90 of 236
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
- Contribution to journal › Article
-
Mark
The interface of population-based cancer registries and biobanks in etiological and clinical research - current and future perspectives.
- Contribution to journal › Article
-
Mark
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women.
- Contribution to journal › Article
-
Mark
Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples.
- Contribution to journal › Article
- 2009
-
Mark
Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies
- Contribution to journal › Article
-
Mark
Risk of invasive cervical cancer in relation to management of abnormal Pap smear results
- Contribution to journal › Article
-
Mark
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
- Contribution to journal › Article
-
Mark
Introduction of human papillomavirus (HPV) vaccination in Sweden
- Contribution to journal › Article
-
Mark
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- Contribution to journal › Article
-
Mark
Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
- Contribution to journal › Article